This Analyst Says GSK Spin-Off Haleon Offers “Best Of Both Consumer Worlds”
Citi group has initiated coverage on GSK plc's (NYSE: GSK) consumer healthcare spin-off Haleon Plc (NYSE: HLN) with a Buy rating and a price target of 360p.
Despite Capital Budget Softness, Long Term Opportunity Remains Intact For Intuitive Surgical: Raymond James Analyst
Yesterday, Intuitive Surgical Inc (NASDAQ:ISRG) reported lower-than-expected Q2 earnings. Raymond James writes, “we were worried about the capital equipment environment, we admittedly…
Volkswagen CEO Herbert Diess To Depart; Porsche Brand’s Oliver Blume Named Successor
Volkswagen AG (OTC:VWAGY) board of directors has appointed Oliver Blume as the new Chairman of the group board of management. Blume…
Strategic Cannabis Execs Making Changes At Companies You Know: Curaleaf, Valens, Copperstate & Delic
As Benzinga Cannabis Capital Conference returns (September 13-14) in Chicago, gathering top CEOs, investors and leaders in the cannabis industry, let's scroll through the latest leadership changes within the space.
Why This Analyst Downgraded Palantir As Economy ‘Appears To Be In Recession’
Palantir Technologies Inc. (NYSE: PLTR) was downgraded from a Buy rating to a Neutral rating with no given price target on Friday by analysts at Monness Crespi Hardt & Co. Inc.